The Singapore Patent Act 2026: What Every Founder and Executive Needs

The Singapore Patent Act 2026: What Every Founder and Executive Needs to Know

Picture a Singapore-based founder who spends eighteen months and substantial capital developing a proprietary process that slashes manufacturing costs. Six months after soft-launching, a competitor releases an identical method — and files a Singapore patent on it first. The competitor now has the enforceable right to exclude everyone else, including the founder who built the invention. That outcome is not hypothetical. It is a direct consequence of how the Patents Act in Singapore works, and it happens more often than most people expect.

Quahe Woo & Palmer LLC (UEN 200911430C), incorporated in Singapore in 2009, is a boutique multi-disciplinary law firm with offices in Singapore and Hong Kong, and a member of the Multilaw international network spanning ASEAN and beyond. The firm's 24-practice-area coverage includes intellectual property, corporate and commercial law, start-up and venture capital, and litigation — giving founders, executives and family-office clients a single point of contact for the legal mechanics that sit beneath their business.

Photo by Yan Krukau on Pexels

What Is Patentable Under the Singapore Patents Act

The Patents Act (Cap. 221) governs the grant of enforceable patents in Singapore and is administered by the Intellectual Property Office of Singapore (IPOS). The statute applies the same foundational test used across most major jurisdictions — an invention must be new, involve an inventive step, and be capable of industrial application — but with local procedural quirks that materially affect outcomes.

Novelty is the first and sharpest requirement. An invention must not form part of the state of the art anywhere in the world before the filing date. The standard is global, not local: a feature already disclosed in a technical paper in Japan or a granted US patent counts as prior art against your Singapore application. This catches founders who publish blog posts, present at conferences, or share details on LinkedIn before filing — all of which can destroy novelty irreversibly. Once that window closes, no patent office in the world will grant protection on that invention.

Inventive step is the second limb. The invention must not be obvious to a person skilled in the relevant field given everything already in the public domain. Obviousness is a fact-specific assessment; IPOS examiners look at whether the invention provides a non-obvious technical advance, not just a different way of achieving the same result. This is where well-documented development records — lab notes, iteration logs, third-party expert assessments — become strategically important during prosecution.

Industrial applicability is the third limb. The invention must be capable of being made or used in some kind of industry. This limb is rarely the sticking point for hardware, chemicals, or software-related inventions, though software patents in Singapore sit in a nuanced zone where the technical character of the contribution matters.

The Act also carries a list of explicit exclusions — subject matter that cannot be patented regardless of whether it meets the three limbs. Business methods, mathematical methods, and purely mental processes are among the exclusions. Some of these carve-outs trip up first-time applicants more often than the substantive novelty test does.

Photo by KATRIN BOLOVTSOVA on Pexels

Filing Routes and the Examination Timeline

Singapore offers three principal routes for obtaining patent protection, each suited to different commercial strategies.

Independent filing in Singapore via IPOS is the direct route: file an application, request examination, and prosecute through the Singapore system. For founders focused on the Singapore, Malaysia and Brunei markets, this is often the most cost-effective starting point. The filing fee for a small entity (generally companies with fewer than 500 employees) is currently around SGD 70 for the first filing, with prosecution and examination fees layered on as the application progresses.

The Patent Cooperation Treaty (PCT) route is for founders who want international protection from day one without filing in every jurisdiction individually. A PCT application preserves the option to enter national phases in up to 150 countries within 30 months of the earliest priority date, buying time to assess market opportunity, find licensees, or attract funding before committing to per-country prosecution costs. Singapore is both a PCT receiving office and a national phase destination.

The SG Patent Prosecution Highway (SG-PPH) is a faster examination option available when a corresponding application has already been found patentable by a partnering patent office — typically IPOS, the Japanese Patent Office, the Korean Intellectual Property Office, or the United States Patent and Trademark Office. The PPH can compress examination timelines meaningfully, which matters when a competitor is close behind.

After filing, the application is published automatically eighteen months from the earliest priority date — making it publicly searchable even before a grant decision. Substantive examination must be requested within that window, and the average examination backlog at IPOS currently runs eighteen months to over three years depending on technology area and workload. The search report, which identifies relevant prior art, typically issues within three to six months of requesting examination. The full filing-to-grant timeline for a Singapore patent commonly spans two to five years.

Photo by Kampus Production on Pexels

Shareholder Agreements and the ACRA Compliance Underlayer

Patents do not exist in isolation. A Singapore company with external investment or multiple founders faces two other legal structures that routinely create exposure — and the consequences surface during funding rounds and investor due diligence.

Under the Companies Act 1967, every Singapore private limited company has a constitution — typically the ACRA Model Constitution, which governs director duties, share transfers, general meetings and corporate machinery. A shareholder agreement (SHA) sits above that constitution as a private, contractual instrument binding only the parties who sign it. Bespoke economic terms — preference share rights, anti-dilution mechanics, drag-along and tag-along provisions — typically need to appear in both documents to be enforceable in the way investors intend.

The practical failure mode we see in practice: a funded company grows to Series A with no SHA, or one drafted from an online template that does not cover the scenarios the term sheet specifies. When a dispute arises — a co-founder exits, an investor wants liquidation preferences enforced, a buyer tables a reverse takeover — the ambiguity in the undocumented terms becomes the dispute itself. A well-drafted SHA from incorporation is materially cheaper than litigating its absence during a live transaction.

ACRA compliance compounds the risk. Under the Companies Act, the Qualified Individual appointed as company secretary carries personal statutory duties. When a company misses an AGM deadline, files its annual return late, or fails to maintain statutory registers in the prescribed form, ACRA can issue fines to the company and to the named Qualified Individual. For private companies heading toward institutional investment, ACRA penalties and overdue filings surface in due diligence — and can delay or condition a funding round just as it reaches close.

Photo by Aayush Bhansali on Pexels

Enforcement and the Cost of Getting It Wrong

Once granted, a Singapore patent confers the exclusive right to exploit the invention in Singapore for the remainder of the 20-year term from filing. The Patents Act allows the patent owner to sue for infringement in the General Division of the High Court. Remedies include injunctions to stop ongoing infringement and damages or an account of profits for past infringement.

The practical cost of enforcement is substantial: contested patent litigation in Singapore routinely runs into hundreds of thousands of Singapore dollars over multiple years. The practical cost of not enforcing a patent — or not obtaining one — is often larger still. Competitors who identify a commercially successful invention and file first can extract licensing fees, gain market exclusivity, or use the patent as a defensive instrument in cross-licensing negotiations.

Beyond patent enforcement, consider the compliance underlayer. Companies incorporated in Singapore must file their Model Constitution with ACRA, lodge annual returns within the prescribed deadlines, and maintain registers in the format ACRA specifies. For companies preparing for a funding round, every overdue filing, unresolved ACRA penalty, and absent SHA is a flag in the investor's legal due diligence. None of them are expensive to fix in isolation. All of them become expensive when they are the reason a term sheet is withdrawn three days before signing.

Frequently Asked Questions

What is the 20-year term under the Singapore Patents Act?
A Singapore patent is granted for 20 years from the filing date, subject to the payment of annual renewal fees. After 20 years the invention enters the public domain and anyone may exploit it.

Can I file a Singapore patent myself?
You can file a DIY application for a simple invention using IPOS's online filing portal, but the examination process — prior art searches, inventive step assessment, claim drafting and prosecution correspondence — requires technical and legal expertise that materially affects the scope of protection granted. Complex inventions with international commercial ambitions almost always benefit from qualified patent counsel.

Does publishing before filing destroy my patent rights?
Yes, in most cases. Public disclosure — including presentations, academic publications, social media posts, or even informal sales demonstrations — before the filing date can be used as prior art against your application. Singapore does have a 12-month grace period for disclosures made by the inventor, but this grace period does not exist in most foreign jurisdictions, making pre-filing disclosure a particularly high-risk strategy for internationally-focused companies.

What happens if my company misses an ACRA annual return filing deadline?
ACRA issues an automatic notification and imposes a late-filing penalty on the company and, where the Qualified Individual is personally liable, on that individual. Accumulated penalties affect the company's regulatory standing and will surface in BizFile+ searches conducted during investor due diligence.

Does a shareholder agreement replace the Model Constitution?
No. The Model Constitution is the company's foundational governance document, filed with ACRA and binding on all members. The shareholder agreement is a separate private contract between shareholders that can modify, supplement or restrict the operation of the Model Constitution on specific matters. The two documents must be read together — discrepancies between them are a common source of shareholder disputes.

How does QWP support founders on patent, corporate and compliance matters?
Quahe Woo & Palmer LLC's Intellectual Property practice assists clients with patent filing, prosecution and IP strategy across multiple jurisdictions. The Corporate & Commercial and Start-up & Venture Capital teams cover incorporation, shareholder agreements, funding rounds and ongoing ACRA compliance from day one. The firm offers fixed-fee packages for qualifying early-stage companies. Contact the team at +65 6622 0366 or email [email protected] to discuss your matter.

Photo by SHOX ART on Pexels

A Singapore patent is a business asset, not just a legal formality. The decisions made in the first months of a company's life — what to protect, how to file, whether the cap table is documented in enforceable instruments, whether compliance filings are current — define the legal terrain the business will operate in for years. Getting that terrain right requires knowing the rules, not just following them.